SlideShare a Scribd company logo
1 of 41
Medical Science Tanzania Cardiology Lectures




             Congestive Heart Failure

                         3. Treatment

                        Prof. Hennersdorf SES




March 2013                ghennersdorf DGK ESC SES            1
General signs and symptoms




March 2013        ghennersdorf DGK ESC SES   2
Definition of Heart Failure CHF
• New York Heart Association (NYHA)
     – I  no visible signs and symptoms
     – II  signs and symptoms at high level exercise
     – III  signs and symptoms at low level exercise
     – IV  no physical exercise possible, bed rest
       necessary


             Worldwide used as functional definition of CHF!


March 2013                ghennersdorf DGK ESC SES             3
Treatment Goals
                 IV
                                                             II        Main treatment goal
                                                                       for chronic disease


                                                             ??
                                                  ??

                  III                       ??               I

         Main treatment goal
         for acute disease                                HTX option




March 2013                     ghennersdorf DGK ESC SES                                4
Therapeutic objectives
• Acute CHF
                                                         Main approach
     – Treatment of life threat                           Vasodilation
                                                        Organ protection
     – Improvement of life quality                       Volume control

• Chronic CHF
     – Improvement of life quality
     – Reduction of Disability
     – Increase of longevity
              Adding life to years rather than years to life


March 2013                ghennersdorf DGK ESC SES                         5
Therapeutic options



               Acute Heart Failure




March 2013         ghennersdorf DGK ESC SES   6
Therapeutic options (ER, ICU)
•   Physical approach in cardiogenic pulmonary edema
     –   Oxygen delivery
     –   Bed rest / upright position
     –   Secure (central) venous line
     –   Urinary catheter
     –   Blood letting

•   Drugs (iv administration)
     – Diuretics (short term, furosemide)
     – Digitalis (?; fast AF ?)
     – Thrombembolic prophylaxis (heparin; PTT necessary)

•   Drugs orally (cave hypotension)
     – Nitroglycerine sublingually
     – Consider ACEI sublingually



March 2013                       ghennersdorf DGK ESC SES   7
Therapeutic options
                        (cardiogenic shock)
•   Volume expansion under hemodynamic control
     – Pulmonary artery cath
     – Arterial pressure line
•   Mechanical assistance: IABP
•   Cathlab: PCI
•   Surgery: revascularization
•   Drugs
     – Catecholamines: Dopamin, Dobutamin
     – Phosphodiesterase (PDE)-Inhibitors: Amrinone, Milrinone (not
        evidence based)
     – Thrombembolic prophylaxis: heparine (PTT)
     – Fast acting diuretics
•   Acid base control
•   Electrolyte contol (potassium)


March 2013                      ghennersdorf DGK ESC SES              8
Therapeutic options


               Chronic Heart Failure




March 2013         ghennersdorf DGK ESC SES   9
Evidence




March 2013   ghennersdorf DGK ESC SES   10
Therapeutic challenge

    Systolic heart failure: mostly common in CHD and RHD
    Drugs and recommendations according to guidelines

    Diastolic heart failure: mostly common in hypertension
    Long term follow up dependent on
    treatment of underlying disease
    Drugs recommendations not yet established




March 2013             ghennersdorf DGK ESC SES              11
Therapeutic options
• First line recommendation: Prevention
     – Prevention of CHD, Hypertension, valvular
       disease, infections
     – Information, home care, transmission of simple
       behavior rules:
             •   Hygiene and clean water supply
             •   Motion: physical activity, limited sport action
             •   Nutrition: salt restriction
             •   Refrain smoking

March 2013                      ghennersdorf DGK ESC SES           12
Therapeutic options
•   Conservative
     – RAS modification
         • ACE-I
         • AT1-receptor antagonists
         • Aldosterone antagonists (Eplerenone ®)
     – beta-AR competition
         • Betablockers
     – classical 3D options
         • Diuretics (fast acting, medium acting; cave potassium)
         • Diet
         • Digitalis (?) not first choice!
     – Others: (Pulmonary artery Hypertension)
                                                                    Avoid
         • Bosentan
                                                                    use of
         • Sildenafil
                                                                    NSAIDs
                                                                    like
                                                                    COXIBs
March 2013                      ghennersdorf DGK ESC SES                     13
ß-Blockade in CHF




March 2013       ghennersdorf DGK ESC SES   14
ß-Blockade in CHF




March 2013       ghennersdorf DGK ESC SES   15
ß-Blockade in CHF
Reduction of adrenergic receptors AR

                                                                         Betablockade:
       NE                                                                receptor recovery,
       NE             Muscle cell; contractility                         function improves
                                                          NE
       E
                                                          NE
                                                          NE
                                                          NE      Muscle cell; contractility
       NE
                                                          E
       NE
                                                          E
       NE
                                                          E
       NE            Muscle cell; contractility
       E
       E
                                                                   AR Recovery
       E
              AR Reduction




 March 2013                            ghennersdorf DGK ESC SES                           16
ß-Blockade in CHF




             Recommended:
             ß1-selective drugs like metoprolol, bisoprolol
             + vasodilatation: carvedilol, nevibolol
March 2013                       ghennersdorf DGK ESC SES     17
Therapeutic options. ACE-I
• Trials
     – CONSENSUS 1987 Captopril
     – SOLVD 1999     Enalapril
     – SAVE 1992         Captopril
     – VHEFT 1991     Enalapril/Hydralazin
     – CIBIS III 2005 Enalapril/Bisoprolol

   Demonstrate highly significant improvement of survival in different stages
   of heart failure (II –IV): Evidence Class A - IA


March 2013                    ghennersdorf DGK ESC SES                          18
Dosage recommendations




March 2013          ghennersdorf DGK ESC SES   19
Dosage recommendations




March 2013          ghennersdorf DGK ESC SES   20
Improvement of HF in cardiac CXR




             before treatment                 after treatment



March 2013                ghennersdorf DGK ESC SES              21
Therapeutic options
• Surgical
     – Heart transplantation, bridging
     – Cardiomyoplasty
• Resynchronizing pacemaker therapy (CRT)
• Stem cell replacement




March 2013            ghennersdorf DGK ESC SES   22
Therapeutic options
• HTX
     – Surgically solved
     – Concomitant therapy problems (rejection) solved
     – Donor problems unsolved and will persist


             But: therapeutic choice for subsets of younger patients
                         with severe symptoms mostly on
                            iv therapy and/or ICU care
                     without chance to recover appropriately.
                           Bridging procedure desirable

March 2013                     ghennersdorf DGK ESC SES                23
Heart transplantation HTX




March 2013           ghennersdorf DGK ESC SES   24
Heart transplantation




March 2013         ghennersdorf DGK ESC SES   25
Heart transplantation




         Christian Neethling Barnard
                                                      3rd september 1967
                                                      original OR theatre
                                                      Groote Schuur Hospital
                                                      Cape Town SAR


March 2013                     ghennersdorf DGK ESC SES                        26
Artificial heart




             Heartmate® for bridging procedures



March 2013          ghennersdorf DGK ESC SES      27
Survival after HTX




March 2013       ghennersdorf DGK ESC SES   28
Therapeutic options: cardiac
             resynchronization therapy CRT




March 2013            ghennersdorf DGK ESC SES   29
Therapeutic options




March 2013        ghennersdorf DGK ESC SES   30
Therapeutic options: resynchronization
                   therapy




March 2013       ghennersdorf DGK ESC SES    31
Therapeutic options: stem cells




March 2013      ghennersdorf DGK ESC SES   32
Therapeutic challenge: home care

•   Medication starts in the hospital
•   Medication continues in household enviroment, rural areas
•   Doctor‘s contacts rare
•   Patient‘s survey difficult.
•   Therefore: narrow control schedules concerning
     – Nurse directed home care
     – Continuous medical education of both patient and personal
        (nurses/doctors)
     – Outpatient visits
     – Establishing telemedical processes




March 2013                  ghennersdorf DGK ESC SES               33
Therapeutic home care options
• Home care (nurse driven)
     – Scheduled visits on regular basis (nurse, AMO)
     – Visits following questionnaire
     – Data acquisition and transmission
       (telemedicine?)
             • Severity of symptoms
             • Daily activities ability
             • Controls
                 –   Medication
                 –   Weight (listing by patient)
                 –   Blood pressure
                 –   other
March 2013                         ghennersdorf DGK ESC SES   34
CHF Questionnaire; example
             How do you feel since last visit? Scale of 10 pts
             In your opinion, are there main changes:
                          breathing
                          weight gain
                          Urinary output
                          palpitation?
             How do you think developed your personal daily
             activities (DAs)?
                          worse
                          same
                          better
             which kind of DAs is mostly impaired?
                          home
                          leisure
                          employment
             What about your medication:
                          intake OK?
                          complaints?
                          self made changes?
                          incompatibilty?
                          wishes?
             Suggestions?


March 2013                 ghennersdorf DGK ESC SES              35
Heart Network
                          Patient




                        Hospital




                           OPD


                   District Hospital


             Dispensary                     Home Care

March 2013       ghennersdorf DGK ESC SES               36
Heart Network: nurse
             Hospital




             Nurse
                                 +



             home care




March 2013               ghennersdorf DGK ESC SES   37
Heart Network: Internet




                    Patient data file, database: EPF*
                    Access by authorized personal
                    throughout the country

                                               *electronic patient file



March 2013          ghennersdorf DGK ESC SES                              38
Heart Network
• Telecardiology (telemedicine)
     – Electronic provision of data transmission
     – Generation of medical data in remote areas (rural)
     – Overcoming of doctors shortages
     – Secure transmission line
     – Targets:
             •   Hospital Centers
             •   Home care physician
             •   Home care nurse
             •   Specialized medical call centers
March 2013                      ghennersdorf DGK ESC SES   39
Heart Network
• Telemedical patient kit
     – Smartphone with Apps (Skype)
     – Balance
     – ECG device
     – Blood pressure device
     – Glukose test kit
     – Finger tip pulse oxymeter
     – Questionnaire

March 2013           ghennersdorf DGK ESC SES   40
The End




March 2013   ghennersdorf DGK ESC SES   41

More Related Content

What's hot

Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failureChoying Chen
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectorisBbconBbcon
 
Non invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndromeNon invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndromeSCGH ED CME
 
cardiogenic shock
cardiogenic shock cardiogenic shock
cardiogenic shock Abdul Waris
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart diseaseRISHIKESAN K V
 
Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)The CRUDEM Foundation
 
Diastolic Heart Failure
Diastolic Heart FailureDiastolic Heart Failure
Diastolic Heart Failure軒名 林
 
Approach to heart failure cases
Approach to heart failure casesApproach to heart failure cases
Approach to heart failure caseshospital
 
2 cardiac emergencies
2 cardiac emergencies2 cardiac emergencies
2 cardiac emergenciesachsan raider
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shockGOPAL GHOSH
 
Congestive Heart Failure
Congestive Heart FailureCongestive Heart Failure
Congestive Heart Failurewayn
 

What's hot (20)

Accute Coronary Syndrome
Accute Coronary SyndromeAccute Coronary Syndrome
Accute Coronary Syndrome
 
Heart failure
Heart failureHeart failure
Heart failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Unstable Angina Pectoris
Unstable Angina PectorisUnstable Angina Pectoris
Unstable Angina Pectoris
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Chf
ChfChf
Chf
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Blood pressure
Blood pressureBlood pressure
Blood pressure
 
Non invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndromeNon invasive cardiac testing for acute coronary syndrome
Non invasive cardiac testing for acute coronary syndrome
 
Ihd and anaesth
Ihd and anaesthIhd and anaesth
Ihd and anaesth
 
cardiogenic shock
cardiogenic shock cardiogenic shock
cardiogenic shock
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart disease
 
Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)
 
Management Of Chf
Management Of ChfManagement Of Chf
Management Of Chf
 
Diastolic Heart Failure
Diastolic Heart FailureDiastolic Heart Failure
Diastolic Heart Failure
 
Approach to heart failure cases
Approach to heart failure casesApproach to heart failure cases
Approach to heart failure cases
 
2 cardiac emergencies
2 cardiac emergencies2 cardiac emergencies
2 cardiac emergencies
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Congestive Heart Failure
Congestive Heart FailureCongestive Heart Failure
Congestive Heart Failure
 

Viewers also liked

Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailureDr. Ashutosh Tiwari
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failureDr Htet
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failureFuad Farooq
 
Heart failure
Heart failureHeart failure
Heart failureUNEP
 
Pathophysiology of congestive heart failure
Pathophysiology of congestive heart failurePathophysiology of congestive heart failure
Pathophysiology of congestive heart failurethunderrajesh
 
recent advance in pharmacotherapy of Heart failure
recent advance in pharmacotherapy of Heart failure recent advance in pharmacotherapy of Heart failure
recent advance in pharmacotherapy of Heart failure priyanka527
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failureIAU Dent
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failurecardilogy
 
Heart Failure management in ICU
Heart Failure management in ICUHeart Failure management in ICU
Heart Failure management in ICUAhmad Y. Alansi
 
Acute heart failure - Ben Cooper
Acute heart failure - Ben CooperAcute heart failure - Ben Cooper
Acute heart failure - Ben Cooperbcooper876
 
Lisinopril in Heart Failure Treatment
Lisinopril in Heart Failure TreatmentLisinopril in Heart Failure Treatment
Lisinopril in Heart Failure Treatmentslmarsh88
 
Surgical management of heart failure
Surgical management of heart failureSurgical management of heart failure
Surgical management of heart failureRamachandra Barik
 
Acute heart failure: diagnosing and managing acute heart failure in adults
Acute heart failure: diagnosing and managing acute heart failure in adultsAcute heart failure: diagnosing and managing acute heart failure in adults
Acute heart failure: diagnosing and managing acute heart failure in adultsEmergency Live
 
Heart failure treatment european guidlines 2012
Heart failure treatment european guidlines 2012Heart failure treatment european guidlines 2012
Heart failure treatment european guidlines 2012Basem Enany
 
Case presentation heart failure
Case presentation heart failureCase presentation heart failure
Case presentation heart failure政諺 郭
 
Congestive Heart Failure Case Study
Congestive Heart Failure Case StudyCongestive Heart Failure Case Study
Congestive Heart Failure Case StudyMegan Smith
 
Heart failure 2016 update
Heart failure 2016  updateHeart failure 2016  update
Heart failure 2016 updateNeeraj Varyani
 

Viewers also liked (20)

Heart Failure
Heart FailureHeart Failure
Heart Failure
 
Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart Failure
 
Guidelines heart failure 2016
Guidelines heart failure 2016Guidelines heart failure 2016
Guidelines heart failure 2016
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failure
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Pathophysiology of congestive heart failure
Pathophysiology of congestive heart failurePathophysiology of congestive heart failure
Pathophysiology of congestive heart failure
 
recent advance in pharmacotherapy of Heart failure
recent advance in pharmacotherapy of Heart failure recent advance in pharmacotherapy of Heart failure
recent advance in pharmacotherapy of Heart failure
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Heart Failure management in ICU
Heart Failure management in ICUHeart Failure management in ICU
Heart Failure management in ICU
 
Acute heart failure - Ben Cooper
Acute heart failure - Ben CooperAcute heart failure - Ben Cooper
Acute heart failure - Ben Cooper
 
Lisinopril in Heart Failure Treatment
Lisinopril in Heart Failure TreatmentLisinopril in Heart Failure Treatment
Lisinopril in Heart Failure Treatment
 
Surgical management of heart failure
Surgical management of heart failureSurgical management of heart failure
Surgical management of heart failure
 
Acute heart failure: diagnosing and managing acute heart failure in adults
Acute heart failure: diagnosing and managing acute heart failure in adultsAcute heart failure: diagnosing and managing acute heart failure in adults
Acute heart failure: diagnosing and managing acute heart failure in adults
 
Drug therapy for heart failure
Drug therapy for heart failureDrug therapy for heart failure
Drug therapy for heart failure
 
Heart failure treatment european guidlines 2012
Heart failure treatment european guidlines 2012Heart failure treatment european guidlines 2012
Heart failure treatment european guidlines 2012
 
Case presentation heart failure
Case presentation heart failureCase presentation heart failure
Case presentation heart failure
 
Congestive Heart Failure Case Study
Congestive Heart Failure Case StudyCongestive Heart Failure Case Study
Congestive Heart Failure Case Study
 
Heart failure 2016 update
Heart failure 2016  updateHeart failure 2016  update
Heart failure 2016 update
 

Similar to Heart failure 2013 Therapy

Antianginal drugs
Antianginal drugsAntianginal drugs
Antianginal drugsajaykumarbp
 
PH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.pptPH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.pptDr-Mani Bharti
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitorSMSRAZA
 
Drugs used in Cardiac Failure
Drugs used in Cardiac FailureDrugs used in Cardiac Failure
Drugs used in Cardiac FailureEneutron
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery diseasemagdy elmasry
 
Anti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa usesAnti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa usesvijiarumugamvsvs
 
CHOs Final Yr. Congestive cardiac failure-2023.pptx
CHOs Final Yr. Congestive cardiac failure-2023.pptxCHOs Final Yr. Congestive cardiac failure-2023.pptx
CHOs Final Yr. Congestive cardiac failure-2023.pptxIbrahimKargbo13
 
Drugs used in congestive heart failure-1
Drugs used in congestive heart failure-1Drugs used in congestive heart failure-1
Drugs used in congestive heart failure-1Goutam Mallik
 
Congestive Cardiac Failure Dr. Prerana.pptx
Congestive Cardiac Failure Dr. Prerana.pptxCongestive Cardiac Failure Dr. Prerana.pptx
Congestive Cardiac Failure Dr. Prerana.pptxDr Prerana Kadam
 
Updated drug therapy of chronic stable angina=Angina of.pptx
Updated drug therapy of chronic stable angina=Angina of.pptxUpdated drug therapy of chronic stable angina=Angina of.pptx
Updated drug therapy of chronic stable angina=Angina of.pptxgadaagadaa1
 
Drugs used in treatment of IHD
Drugs used in treatment of IHDDrugs used in treatment of IHD
Drugs used in treatment of IHDPravin Prasad
 
1st presentation C Delles.pptx
1st presentation C Delles.pptx1st presentation C Delles.pptx
1st presentation C Delles.pptxMohamedELRashidy21
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectorismzabihi
 
Anti Anginal Drugs and its side affect and uses
Anti Anginal  Drugs and its side affect and usesAnti Anginal  Drugs and its side affect and uses
Anti Anginal Drugs and its side affect and useswajidullah9551
 
Pathophysiological approach of Angina Pectoris
Pathophysiological approach of Angina PectorisPathophysiological approach of Angina Pectoris
Pathophysiological approach of Angina PectorisSreenivasa Reddy Thalla
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart FailureAkash Agnihotri
 
Angina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptxAngina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptxMuhammad Kamal Hossain
 
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptxAntianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptxMrSALAJKHARE
 

Similar to Heart failure 2013 Therapy (20)

Vasoactive Medications.pptx
Vasoactive Medications.pptxVasoactive Medications.pptx
Vasoactive Medications.pptx
 
Antianginal drugs
Antianginal drugsAntianginal drugs
Antianginal drugs
 
PH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.pptPH1.28 Angina pectoris MANI.ppt
PH1.28 Angina pectoris MANI.ppt
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
 
Drugs used in Cardiac Failure
Drugs used in Cardiac FailureDrugs used in Cardiac Failure
Drugs used in Cardiac Failure
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery disease
 
Anti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa usesAnti-anginal Drugs pharmacology moa uses
Anti-anginal Drugs pharmacology moa uses
 
CHOs Final Yr. Congestive cardiac failure-2023.pptx
CHOs Final Yr. Congestive cardiac failure-2023.pptxCHOs Final Yr. Congestive cardiac failure-2023.pptx
CHOs Final Yr. Congestive cardiac failure-2023.pptx
 
Drugs used in congestive heart failure-1
Drugs used in congestive heart failure-1Drugs used in congestive heart failure-1
Drugs used in congestive heart failure-1
 
Antianginal drugs (VK)
Antianginal drugs (VK)Antianginal drugs (VK)
Antianginal drugs (VK)
 
Congestive Cardiac Failure Dr. Prerana.pptx
Congestive Cardiac Failure Dr. Prerana.pptxCongestive Cardiac Failure Dr. Prerana.pptx
Congestive Cardiac Failure Dr. Prerana.pptx
 
Updated drug therapy of chronic stable angina=Angina of.pptx
Updated drug therapy of chronic stable angina=Angina of.pptxUpdated drug therapy of chronic stable angina=Angina of.pptx
Updated drug therapy of chronic stable angina=Angina of.pptx
 
Drugs used in treatment of IHD
Drugs used in treatment of IHDDrugs used in treatment of IHD
Drugs used in treatment of IHD
 
1st presentation C Delles.pptx
1st presentation C Delles.pptx1st presentation C Delles.pptx
1st presentation C Delles.pptx
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Anti Anginal Drugs and its side affect and uses
Anti Anginal  Drugs and its side affect and usesAnti Anginal  Drugs and its side affect and uses
Anti Anginal Drugs and its side affect and uses
 
Pathophysiological approach of Angina Pectoris
Pathophysiological approach of Angina PectorisPathophysiological approach of Angina Pectoris
Pathophysiological approach of Angina Pectoris
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart Failure
 
Angina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptxAngina Pectoris and Antianginal Drugs_Kamal.pptx
Angina Pectoris and Antianginal Drugs_Kamal.pptx
 
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptxAntianginal Drugs Pharmacology 5th sem B.Pharm.pptx
Antianginal Drugs Pharmacology 5th sem B.Pharm.pptx
 

More from Gunter Hennersdorf

More from Gunter Hennersdorf (11)

herzanatomie-pptx.pptx
herzanatomie-pptx.pptxherzanatomie-pptx.pptx
herzanatomie-pptx.pptx
 
HI-Herz.BIKE Saar
HI-Herz.BIKE SaarHI-Herz.BIKE Saar
HI-Herz.BIKE Saar
 
Herzbikesaar 2016 Endergebnisse
Herzbikesaar 2016 EndergebnisseHerzbikesaar 2016 Endergebnisse
Herzbikesaar 2016 Endergebnisse
 
HI-Herz.BIKE Saar
HI-Herz.BIKE SaarHI-Herz.BIKE Saar
HI-Herz.BIKE Saar
 
Bls2016b
Bls2016bBls2016b
Bls2016b
 
HI-Herz.BIKE Saar
HI-Herz.BIKE Saar HI-Herz.BIKE Saar
HI-Herz.BIKE Saar
 
Erste Ergebnisse des Herz.BIKE Saar-Projekts (erstes Halbjahr 2015)
Erste Ergebnisse des Herz.BIKE Saar-Projekts (erstes Halbjahr 2015)Erste Ergebnisse des Herz.BIKE Saar-Projekts (erstes Halbjahr 2015)
Erste Ergebnisse des Herz.BIKE Saar-Projekts (erstes Halbjahr 2015)
 
Präsentation Herz Bike Saar 04
Präsentation Herz Bike Saar 04Präsentation Herz Bike Saar 04
Präsentation Herz Bike Saar 04
 
Patientenvortrag Herzmuskelschwäche
Patientenvortrag HerzmuskelschwächePatientenvortrag Herzmuskelschwäche
Patientenvortrag Herzmuskelschwäche
 
Hypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyHypertension 2013 Pathophysiology
Hypertension 2013 Pathophysiology
 
Hypertension 2013 Diagnostic Procedures
Hypertension 2013 Diagnostic ProceduresHypertension 2013 Diagnostic Procedures
Hypertension 2013 Diagnostic Procedures
 

Heart failure 2013 Therapy

  • 1. Medical Science Tanzania Cardiology Lectures Congestive Heart Failure 3. Treatment Prof. Hennersdorf SES March 2013 ghennersdorf DGK ESC SES 1
  • 2. General signs and symptoms March 2013 ghennersdorf DGK ESC SES 2
  • 3. Definition of Heart Failure CHF • New York Heart Association (NYHA) – I  no visible signs and symptoms – II  signs and symptoms at high level exercise – III  signs and symptoms at low level exercise – IV  no physical exercise possible, bed rest necessary Worldwide used as functional definition of CHF! March 2013 ghennersdorf DGK ESC SES 3
  • 4. Treatment Goals IV II Main treatment goal for chronic disease ?? ?? III ?? I Main treatment goal for acute disease HTX option March 2013 ghennersdorf DGK ESC SES 4
  • 5. Therapeutic objectives • Acute CHF Main approach – Treatment of life threat Vasodilation Organ protection – Improvement of life quality Volume control • Chronic CHF – Improvement of life quality – Reduction of Disability – Increase of longevity Adding life to years rather than years to life March 2013 ghennersdorf DGK ESC SES 5
  • 6. Therapeutic options Acute Heart Failure March 2013 ghennersdorf DGK ESC SES 6
  • 7. Therapeutic options (ER, ICU) • Physical approach in cardiogenic pulmonary edema – Oxygen delivery – Bed rest / upright position – Secure (central) venous line – Urinary catheter – Blood letting • Drugs (iv administration) – Diuretics (short term, furosemide) – Digitalis (?; fast AF ?) – Thrombembolic prophylaxis (heparin; PTT necessary) • Drugs orally (cave hypotension) – Nitroglycerine sublingually – Consider ACEI sublingually March 2013 ghennersdorf DGK ESC SES 7
  • 8. Therapeutic options (cardiogenic shock) • Volume expansion under hemodynamic control – Pulmonary artery cath – Arterial pressure line • Mechanical assistance: IABP • Cathlab: PCI • Surgery: revascularization • Drugs – Catecholamines: Dopamin, Dobutamin – Phosphodiesterase (PDE)-Inhibitors: Amrinone, Milrinone (not evidence based) – Thrombembolic prophylaxis: heparine (PTT) – Fast acting diuretics • Acid base control • Electrolyte contol (potassium) March 2013 ghennersdorf DGK ESC SES 8
  • 9. Therapeutic options Chronic Heart Failure March 2013 ghennersdorf DGK ESC SES 9
  • 10. Evidence March 2013 ghennersdorf DGK ESC SES 10
  • 11. Therapeutic challenge Systolic heart failure: mostly common in CHD and RHD Drugs and recommendations according to guidelines Diastolic heart failure: mostly common in hypertension Long term follow up dependent on treatment of underlying disease Drugs recommendations not yet established March 2013 ghennersdorf DGK ESC SES 11
  • 12. Therapeutic options • First line recommendation: Prevention – Prevention of CHD, Hypertension, valvular disease, infections – Information, home care, transmission of simple behavior rules: • Hygiene and clean water supply • Motion: physical activity, limited sport action • Nutrition: salt restriction • Refrain smoking March 2013 ghennersdorf DGK ESC SES 12
  • 13. Therapeutic options • Conservative – RAS modification • ACE-I • AT1-receptor antagonists • Aldosterone antagonists (Eplerenone ®) – beta-AR competition • Betablockers – classical 3D options • Diuretics (fast acting, medium acting; cave potassium) • Diet • Digitalis (?) not first choice! – Others: (Pulmonary artery Hypertension) Avoid • Bosentan use of • Sildenafil NSAIDs like COXIBs March 2013 ghennersdorf DGK ESC SES 13
  • 14. ß-Blockade in CHF March 2013 ghennersdorf DGK ESC SES 14
  • 15. ß-Blockade in CHF March 2013 ghennersdorf DGK ESC SES 15
  • 16. ß-Blockade in CHF Reduction of adrenergic receptors AR Betablockade: NE receptor recovery, NE Muscle cell; contractility function improves NE E NE NE NE Muscle cell; contractility NE E NE E NE E NE Muscle cell; contractility E E AR Recovery E AR Reduction March 2013 ghennersdorf DGK ESC SES 16
  • 17. ß-Blockade in CHF Recommended: ß1-selective drugs like metoprolol, bisoprolol + vasodilatation: carvedilol, nevibolol March 2013 ghennersdorf DGK ESC SES 17
  • 18. Therapeutic options. ACE-I • Trials – CONSENSUS 1987 Captopril – SOLVD 1999 Enalapril – SAVE 1992 Captopril – VHEFT 1991 Enalapril/Hydralazin – CIBIS III 2005 Enalapril/Bisoprolol Demonstrate highly significant improvement of survival in different stages of heart failure (II –IV): Evidence Class A - IA March 2013 ghennersdorf DGK ESC SES 18
  • 19. Dosage recommendations March 2013 ghennersdorf DGK ESC SES 19
  • 20. Dosage recommendations March 2013 ghennersdorf DGK ESC SES 20
  • 21. Improvement of HF in cardiac CXR before treatment after treatment March 2013 ghennersdorf DGK ESC SES 21
  • 22. Therapeutic options • Surgical – Heart transplantation, bridging – Cardiomyoplasty • Resynchronizing pacemaker therapy (CRT) • Stem cell replacement March 2013 ghennersdorf DGK ESC SES 22
  • 23. Therapeutic options • HTX – Surgically solved – Concomitant therapy problems (rejection) solved – Donor problems unsolved and will persist But: therapeutic choice for subsets of younger patients with severe symptoms mostly on iv therapy and/or ICU care without chance to recover appropriately. Bridging procedure desirable March 2013 ghennersdorf DGK ESC SES 23
  • 24. Heart transplantation HTX March 2013 ghennersdorf DGK ESC SES 24
  • 25. Heart transplantation March 2013 ghennersdorf DGK ESC SES 25
  • 26. Heart transplantation Christian Neethling Barnard 3rd september 1967 original OR theatre Groote Schuur Hospital Cape Town SAR March 2013 ghennersdorf DGK ESC SES 26
  • 27. Artificial heart Heartmate® for bridging procedures March 2013 ghennersdorf DGK ESC SES 27
  • 28. Survival after HTX March 2013 ghennersdorf DGK ESC SES 28
  • 29. Therapeutic options: cardiac resynchronization therapy CRT March 2013 ghennersdorf DGK ESC SES 29
  • 30. Therapeutic options March 2013 ghennersdorf DGK ESC SES 30
  • 31. Therapeutic options: resynchronization therapy March 2013 ghennersdorf DGK ESC SES 31
  • 32. Therapeutic options: stem cells March 2013 ghennersdorf DGK ESC SES 32
  • 33. Therapeutic challenge: home care • Medication starts in the hospital • Medication continues in household enviroment, rural areas • Doctor‘s contacts rare • Patient‘s survey difficult. • Therefore: narrow control schedules concerning – Nurse directed home care – Continuous medical education of both patient and personal (nurses/doctors) – Outpatient visits – Establishing telemedical processes March 2013 ghennersdorf DGK ESC SES 33
  • 34. Therapeutic home care options • Home care (nurse driven) – Scheduled visits on regular basis (nurse, AMO) – Visits following questionnaire – Data acquisition and transmission (telemedicine?) • Severity of symptoms • Daily activities ability • Controls – Medication – Weight (listing by patient) – Blood pressure – other March 2013 ghennersdorf DGK ESC SES 34
  • 35. CHF Questionnaire; example How do you feel since last visit? Scale of 10 pts In your opinion, are there main changes: breathing weight gain Urinary output palpitation? How do you think developed your personal daily activities (DAs)? worse same better which kind of DAs is mostly impaired? home leisure employment What about your medication: intake OK? complaints? self made changes? incompatibilty? wishes? Suggestions? March 2013 ghennersdorf DGK ESC SES 35
  • 36. Heart Network Patient Hospital OPD District Hospital Dispensary Home Care March 2013 ghennersdorf DGK ESC SES 36
  • 37. Heart Network: nurse Hospital Nurse + home care March 2013 ghennersdorf DGK ESC SES 37
  • 38. Heart Network: Internet Patient data file, database: EPF* Access by authorized personal throughout the country *electronic patient file March 2013 ghennersdorf DGK ESC SES 38
  • 39. Heart Network • Telecardiology (telemedicine) – Electronic provision of data transmission – Generation of medical data in remote areas (rural) – Overcoming of doctors shortages – Secure transmission line – Targets: • Hospital Centers • Home care physician • Home care nurse • Specialized medical call centers March 2013 ghennersdorf DGK ESC SES 39
  • 40. Heart Network • Telemedical patient kit – Smartphone with Apps (Skype) – Balance – ECG device – Blood pressure device – Glukose test kit – Finger tip pulse oxymeter – Questionnaire March 2013 ghennersdorf DGK ESC SES 40
  • 41. The End March 2013 ghennersdorf DGK ESC SES 41